Nprl3 is required for normal development of the cardiovascular system.

C16orf35 is a conserved and widely expressed gene lying adjacent to the human α-globin cluster in all vertebrate species. In-depth sequence analysis shows that C16orf35 (now called NPRL3) is an orthologue of the yeast gene Npr3 (nitrogen permease regulator 3) and, furthermore, is a paralogue of its...

Full description

Bibliographic Details
Main Authors: Kowalczyk, MS, Hughes, J, Babbs, C, Sanchez-Pulido, L, Szumska, D, Sharpe, J, Sloane-Stanley, J, Morriss-Kay, G, Smoot, L, Roberts, A, Watkins, H, Bhattacharya, S, Gibbons, R, Ponting, C, Wood, W, Higgs, D
Format: Journal article
Language:English
Published: 2012
_version_ 1826258914438545408
author Kowalczyk, MS
Hughes, J
Babbs, C
Sanchez-Pulido, L
Szumska, D
Sharpe, J
Sloane-Stanley, J
Morriss-Kay, G
Smoot, L
Roberts, A
Watkins, H
Bhattacharya, S
Gibbons, R
Ponting, C
Wood, W
Higgs, D
author_facet Kowalczyk, MS
Hughes, J
Babbs, C
Sanchez-Pulido, L
Szumska, D
Sharpe, J
Sloane-Stanley, J
Morriss-Kay, G
Smoot, L
Roberts, A
Watkins, H
Bhattacharya, S
Gibbons, R
Ponting, C
Wood, W
Higgs, D
author_sort Kowalczyk, MS
collection OXFORD
description C16orf35 is a conserved and widely expressed gene lying adjacent to the human α-globin cluster in all vertebrate species. In-depth sequence analysis shows that C16orf35 (now called NPRL3) is an orthologue of the yeast gene Npr3 (nitrogen permease regulator 3) and, furthermore, is a paralogue of its protein partner Npr2. The yeast Npr2/3 dimeric protein complex senses amino acid starvation and appropriately adjusts cell metabolism via the TOR pathway. Here we have analysed a mouse model in which expression of Nprl3 has been abolished using homologous recombination. The predominant effect on RNA expression appears to involve genes that regulate protein synthesis and cell cycle, consistent with perturbation of the mTOR pathway. Embryos homozygous for this mutation die towards the end of gestation with a range of cardiovascular defects, including outflow tract abnormalities and ventriculoseptal defects consistent with previous observations, showing that perturbation of the mTOR pathway may affect development of the myocardium. NPRL3 is a candidate gene for harbouring mutations in individuals with developmental abnormalities of the cardiovascular system.
first_indexed 2024-03-06T18:41:34Z
format Journal article
id oxford-uuid:0d07256e-2ef6-4516-9643-6a1deef2dc4f
institution University of Oxford
language English
last_indexed 2024-03-06T18:41:34Z
publishDate 2012
record_format dspace
spelling oxford-uuid:0d07256e-2ef6-4516-9643-6a1deef2dc4f2022-03-26T09:38:25ZNprl3 is required for normal development of the cardiovascular system.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0d07256e-2ef6-4516-9643-6a1deef2dc4fEnglishSymplectic Elements at Oxford2012Kowalczyk, MSHughes, JBabbs, CSanchez-Pulido, LSzumska, DSharpe, JSloane-Stanley, JMorriss-Kay, GSmoot, LRoberts, AWatkins, HBhattacharya, SGibbons, RPonting, CWood, WHiggs, DC16orf35 is a conserved and widely expressed gene lying adjacent to the human α-globin cluster in all vertebrate species. In-depth sequence analysis shows that C16orf35 (now called NPRL3) is an orthologue of the yeast gene Npr3 (nitrogen permease regulator 3) and, furthermore, is a paralogue of its protein partner Npr2. The yeast Npr2/3 dimeric protein complex senses amino acid starvation and appropriately adjusts cell metabolism via the TOR pathway. Here we have analysed a mouse model in which expression of Nprl3 has been abolished using homologous recombination. The predominant effect on RNA expression appears to involve genes that regulate protein synthesis and cell cycle, consistent with perturbation of the mTOR pathway. Embryos homozygous for this mutation die towards the end of gestation with a range of cardiovascular defects, including outflow tract abnormalities and ventriculoseptal defects consistent with previous observations, showing that perturbation of the mTOR pathway may affect development of the myocardium. NPRL3 is a candidate gene for harbouring mutations in individuals with developmental abnormalities of the cardiovascular system.
spellingShingle Kowalczyk, MS
Hughes, J
Babbs, C
Sanchez-Pulido, L
Szumska, D
Sharpe, J
Sloane-Stanley, J
Morriss-Kay, G
Smoot, L
Roberts, A
Watkins, H
Bhattacharya, S
Gibbons, R
Ponting, C
Wood, W
Higgs, D
Nprl3 is required for normal development of the cardiovascular system.
title Nprl3 is required for normal development of the cardiovascular system.
title_full Nprl3 is required for normal development of the cardiovascular system.
title_fullStr Nprl3 is required for normal development of the cardiovascular system.
title_full_unstemmed Nprl3 is required for normal development of the cardiovascular system.
title_short Nprl3 is required for normal development of the cardiovascular system.
title_sort nprl3 is required for normal development of the cardiovascular system
work_keys_str_mv AT kowalczykms nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT hughesj nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT babbsc nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT sanchezpulidol nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT szumskad nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT sharpej nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT sloanestanleyj nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT morrisskayg nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT smootl nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT robertsa nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT watkinsh nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT bhattacharyas nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT gibbonsr nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT pontingc nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT woodw nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem
AT higgsd nprl3isrequiredfornormaldevelopmentofthecardiovascularsystem